CIBC Asset Management Inc

Position in NVS — Novartis AG

CIK 1021926 Toronto, A6

Position in NVS

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$4,401,324

+$192,145 QoQ

Shares Held

28,084

+1.9% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#287

of 1,603 holders

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CIBC Asset Management Inc holds $1,274,158,939 across 15 Drug Manufacturers - General names. NVS ranks #11 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	282,998	$339,436,319
2	JNJ	Johnson & Johnson	994,831	$252,657,229
3	ABBV	AbbVie Inc.	747,319	$188,055,353
4	MRK	Merck & Co., Inc.	1,155,669	$148,503,466
5	AMGN	Amgen Inc	394,840	$142,979,460
6	GILD	Gilead Sciences, Inc.	664,533	$83,957,099
7	BMY	Bristol Myers Squibb Co	776,340	$44,732,710
8	PFE	Pfizer Inc	1,840,616	$44,322,033

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,401,324	28,084	+1.9%	Shares	Sole	2026-08-03
2026-03-31	$4,209,179	27,556	+4.9%	Shares	Sole	2026-05-12
2025-12-31	$3,621,017	26,264	+1.1%	Shares	Sole	2026-02-10
2025-09-30	$3,332,829	25,989	+50.2%	Shares	Sole	2025-10-31
2025-06-30	$2,094,320	17,307	+5.6%	Shares	Sole	2025-08-14
2025-03-31	$1,826,711	16,386	-14.2%	Shares	Sole	2025-05-13
2024-12-31	$1,859,496	19,109	+0.1%	Shares	Sole	2025-01-31
2024-09-30	$2,195,616	19,089	-21.4%	Shares	Sole	2024-11-06
2024-06-30	$2,585,168	24,283	+325.2%	Shares	Sole	2024-08-01
2022-03-31	$501,140	5,711	+96.5%	Shares	Sole	2022-05-06
2021-03-31	$248,404	2,906	-90.2%	Shares	Sole	2021-05-14
2020-12-31	$2,794,466	29,593	+15.1%	Shares	Sole	2021-02-03
2020-09-30	$2,235,567	25,708	-7.2%	Shares	Sole	2020-11-05
2020-06-30	$2,419,580	27,703	-35.5%	Shares	Sole	2020-07-28
2020-03-31	$3,538,589	42,918	—	Shares	Sole	2020-04-30
No filing history on record for this holder in this stock.